The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Take­da trims op­er­a­tions at Aus­tri­an site, lays off 190 staffers

Last year

Up­dat­ed: Sam­sung Bio leans in­to ADC, gene ther­a­py is an ‘area of in­ter­est’

Last year

No­vo un­like­ly to out­source API pro­duc­tion for GLP-1s but will stay en­gaged with fill-fin­ish part­ners

Last year

Evonik lays off 2,000 staffers; Eu­rek­aBio gets $40M for vi­ral vec­tor pro­duc­tion; Sarep­ta un­fazed by No­vo-Catal­ent deal

Last year

As­traZeneca al­lo­cates £650M to boost its UK man­u­fac­tur­ing, cam­pus foot­print 

Last year

Sen­ate com­mit­tee ad­vances bill tar­get­ing Chi­nese man­u­fac­tur­ers as BIO faces at­tack for back­ing WuXi

Last year
China
Pharma

Aus­tralian bio­phar­ma buys ra­dioiso­tope pro­duc­er in its next step to ‘dou­ble’ ca­pac­i­ty in 2024 

Last year
Deals

Pfiz­er to 'wind down con­struc­tion' of Seagen's $350M man­u­fac­tur­ing site

Last year

Mod­er­na lays off man­u­fac­tur­ing work­ers in Mass­a­chu­setts to 're­size' Covid-19 foot­print

Last year
People

Telix boosts in-house ra­dio­phar­ma man­u­fac­tur­ing; Dy­navax im­proves vac­cine pro­duc­tion costs

Last year

Eu­roAPI’s blue­print for ‘lean­er’ op­er­a­tions in­cludes drop­ping prod­ucts, po­ten­tial lay­offs and sites put on ice

Last year

Io­vance’s Am­tagvi sees ‘healthy de­mand’ af­ter US ap­proval

Last year
Pharma
Cell/Gene Tx

So­ci­etal CD­MO to be bought by an­oth­er man­u­fac­tur­er, Cor­eRx, for $1.10 a share

Last year
Deals

Califf lays out drug short­age land­scape, talks post-mar­ket da­ta col­lec­tion for ac­cel­er­at­ed ap­provals

Last year
Pharma
FDA+

Jor­dan­ian OTC drug man­u­fac­tur­er re­ceives FDA warn­ing let­ter over mul­ti­ple ‘un­ac­cept­able haz­ards’

Last year
Pharma

Bris­tol My­ers eyes In­dia as home of its largest site out­side US by 2025, maps $400M Ire­land ex­pan­sion

Last year
R&D
Pharma

Ther­mo Fish­er down­sized by 8,000 work­ers in 2023 amid rev­enue de­cline  

Last year
People
Outsourcing

FDA re­jects Melin­ta, Ve­na­torx’s UTI an­tibi­ot­ic over CMC is­sues

Last year
FDA+

Space man­u­fac­tur­ing re­turns to Earth; Charles Riv­er ex­pands an­ti­body man­u­fac­tur­ing of­fer­ings

Last year

No­vavax and Gavi set­tle over Covid-19 vac­cine part­ner­ship dis­pute 

Last year
Deals

Ap­peals court re­vives suit against Sanofi's Gen­zyme over ac­cess to Fab­ry dis­ease drug

Last year
Law

Chi­nese API man­u­fac­tur­er re­ceives FDA warn­ing let­ter af­ter QC em­ploy­ee says test re­sults 'in my mind'

Last year
China
FDA+

Re­silience al­lo­cates $225M to ex­pand man­u­fac­tur­ing ca­pac­i­ty in Cincin­nati

Last year

WuXi AppTec sub­sidiary to man­u­fac­ture Io­vance’s sol­id tu­mor TIL ther­a­py in US

Last year
First page Previous page 15161718192021 Next page Last page
A service from the Financial Times